Tove Wallström
Affiliated to Research
E-mail: tove.wallstrom@ki.se
Visiting address: Södersjukhuset, Sjukhusbacken 10, 11883 Stockholm
Postal address: S1 Klinisk forskning och utbildning, Södersjukhuset, S1 KI SÖS Forskning Kvinnosjukvård Itzel, 118 83 Stockholm
Part of:
- Department of Clinical Science and Education, Södersjukhuset
- Eva Wiberg-Itzel's research group
Articles
- Article: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2025;132(3):288-296Svensk E; Bessfelt E; Wendel SB; Kallner HK; Wallstroem T
- Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2025;104(1):194-202Frykman J; Nilsson E; Wiberg-Itzel E; Wallstrom T
- Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(11):2296-2305Olsson NY; Bartfai ED; Amark H; Wallstroem T
- Article: BMJ-BRITISH MEDICAL JOURNAL. 2024;385:e079014Bergendahl S; Jonsson M; Hesselman S; Ankarcrona V; Leijonhufvud A; Wihlback A-C; Wallstrom T; Rydstrom E; Friberg H; Kallner HK; Wendel SB
- Article: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2024;35(25):8521-8529Karlsson S; Patavoukas E; Sterpu I; Wallstrom T; Wiberg-Itzel E
- Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2022;27(5):409-417Envall N; Wallstrom T; Danielsson KG; Kallner HK
- Article: PLOS ONE. 2022;17(2):e0263685Bjorklund J; Wiberg-Itzel E; Wallstrom T
- Article: BMC PREGNANCY AND CHILDBIRTH. 2021;21(1):355Strandberg M; Wallstrom T; Wiberg-Itzel E
- Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2020;99(12):1626-1631Remaeus K; Savchenko J; Wendel SB; Gidlof SB; Graner S; Jones E; Molin J; Saltvedt S; Wallstrom T; Pettersson K
- Article: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2019;126(9):1148-1155Wallstrom T; Strandberg M; Gemzell-Danielsson K; Pilo C; Jarnbert-Pettersson H; Friman-Mathiasson M; Wiberg-Itzel E
- Journal article: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2019;234:e116Wallström T; Björklund J; Frykman J; Wiberg-Itzel E
- Article: PLOS ONE. 2018;13(7):e0200024Wallstrom T; Bjorklund J; Frykman J; Jarnbert-Pettersson H; Akerud H; Darj E; Gemzell-Danielsson K; Wiberg-Itzel E
- Article: BIOMED RESEARCH INTERNATIONAL. 2017;2017:6840592-9Wallstrom T; Jarnbert-Pettersson H; Stenson D; Akerud H; Darj E; Gemzell-Danielsson K; Wiberg-Itzel E
- Article: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2016;29(20):3286-3291Stenson D; Wallstrom T; Sjostrand M; Akerud H; Gemzell-Danielsson K; Wiberg-Itzel E
- Article: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2015;28(16):1912-1916Wallstrom T; Hellgren C; Akerud H; Wiberg-Itzel E
- Journal article: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2012;119(S3):s517Wallstrom T; Akerud H; Wiberg‐Itzel E
All other publications
- Editorial comment: OBSTETRICAL & GYNECOLOGICAL SURVEY. 2024;79(12):697-699Bergendahl S; Jonsson M; Hesselman S; Ankarcrona V; Leijonhufvud A; Wihlbaeck A-C; Wallstrom T; Rydstrom E; Friberg H; Kallner HK; Wendel SB
- Preprint: RESEARCH SQUARE. 2019Strandberg M; Wallström T; Wiberg-Itzel E
Grants
- Swedish Research Council1 December 2021 - 30 November 2025Purpose and aim: The Swedish induction rate was 19%. Due to recently published results showing decreased perinatal mortality for induction at 41 instead of 42 weeks, an increase to about 30% is expected. Induction is associated with longer stay at the delivery unit. It has been suggested that women could return home and be re-admitted at start of active labor, so-called outpatient induction. Outpatient induction could increase patient satisfaction and save healthcare resources. However, safety and efficacy have not been established. We aim to fill this knowledge gap by investigating safety, efficacy, acceptability, and cost-effectiveness of outpatient compared to hospital induction in low-risk pregnancies.Study design: A national, multicentre register-based randomized controlled trial utilizing data from several registries in Sweden. Additional data will be collected using validated questionnaires and interviews.Population:Low-risk women planned for induction (n=8890)Intervention: Outpatient inductionControl:Hospital inductionOutcomes:Primary: 1) composite outcome of severe neonatal morbidity or mortality, 2) efficacy (vaginal delivery)Secondary: further neonatal and maternal health outcomesthe woman’s, partner’s and caregiver’s experienceshealth economicsfuture pregnancy outcomesImpact: If safety and efficacy can be established, outpatient induction has the potential to increase patient satisfaction while contributing to a better use of healthcare resources.
Employments
- Affiliated to Research, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2023-2026
Degrees and Education
- Degree Of Doctor Of Philosophy, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2018
- University Medical Degree, Karolinska Institutet, 2005